Association between use of transdermal tulobuterol and short-term outcomes in patients with stroke and underlying chronic obstructive pulmonary disease: A retrospective cohort study
Transdermal tulobuterol, a long-acting beta agonist in a transdermal form, is available in some countries, including Japan, Korea, and China. It may provide an alternative treatment option for the management of chronic obstructive pulmonary disease (COPD) in patients who are unable to effectively us...
Saved in:
Published in | Medicine (Baltimore) Vol. 102; no. 38; p. e35032 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Hagerstown, MD
Lippincott Williams & Wilkins
22.09.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!